ROIVANT
Live / Registered — Registered (as of 10 Feb 2026)
What this means for you
Registered since 10 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99121352
- Registration number
- 8133077
- Mark type
- Stylized text
- Filed
- 04 Apr 2025
- Published for opposition
- 23 Dec 2025
- Registered
- 10 Feb 2026
- Attorney of record
- Joyce M. Ferraro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions
Owner
- Roivant Sciences GmbH, Basel, CH
- Roivant Sciences GmbH, Basel, CH
- Roivant Sciences GmbH, Basel, CH
Prosecution history
- 10 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION WRITTEN
- 03 Sept 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 03 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2025 — ASSIGNED TO EXAMINER